Autopsy report · NCT05563168

Study Evaluating Diltiazem in Combination With Standard Treatment in the Management of Patients Hospitalized With COVID-19 Pneumonia

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“the epidemiological situation has changed considerably.”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 2
Sponsor: Hospices Civils de Lyon
Sponsor type: University, hospital or other
Conditions: COVID-19
Interventions: DILTIAZEM TEVA 60 mg or placebo
Participants: 0
Sites: 21
Countries: France

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.